Design
Review
Authors
Loading...
May guide CCB selection by vascular vs myocardial selectivity; leaves open updated outcome trials.
Highlights the pharmacological and clinical distinctions between dihydropyridine and non-dihydropyridine calcium channel antagonists.
Lionel H. Opie (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: